Myeloproliferative Neoplasms: Targeting CALR With Novel Therapy

Key opinion leaders on myeloproliferative neoplasms review the potential of CALR as a therapeutic target following data from the ASH 2022 Annual Meeting.

Related Videos
View All
Related Content